843P

REVISION 30 CAPSULES

REVISION 30 CAPSULES

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

REVISION

Description
A dietary supplement recommended for those with reduced dietary intake or increased need for these nutrients. Tagetes erecta has antioxidant properties and contributes to healthy vision.
Vitis vinifera contributes to the functionality of the microcirculation (heavy legs), as an antioxidant and to the regular functioning of the cardiovascular system.
Pomegranate is useful as an antioxidant.
Giant blueberries and blackberries contribute to the functionality of the microcirculation (heavy legs), to the well-being of eyesight, as an antioxidant and to the regularity of intestinal transit.
Cranberry contributes to the drainage of body fluids, to the functionality of the urinary tract, as an antioxidant and to the regularity of intestinal transit.
Vitamin E contributes to the protection of cells from oxidative stress.

Ingredients
Red and blue fruit blend (RICHBERRY 6,000) [grape (Vitis vinifera L.) seeds 100:1, pomegranate (Punica granatum L.) fruit, blueberry (Vaccinium corymbosum L.) fruit, strawberry (Fragaria vesca L.) false fruit 36:1, cranberry (Vaccinium macrocarpon aiton) fruit 36:1, raspberry (Rubus idaeus L.) leaves 36:1, blueberry (Vaccinium Myrtillus L.) fruit] >6,000 ORAC, tagetes erecta capitula >20% lutein; coating: food gelatin capsule; Tagetes erecta capitula >10% zeaxanthin, phosphatidylserine >20% (contains soy ), DL-alpha-tocopheryl acetate (vitamin E) 50% powder; anti-caking agent: microcrystalline cellulose, magnesium salts of fatty acids, silicon dioxide.

Nutritional characteristics
Average values for 1 capsule
Richberry 6.000 (mix of red and blue fruits) >6.000 ORAC 200 mg
Tagetes erecta provides dust
lutein
zeaxanthin
150 mg
20 mg
5 mg
Phosphatidyl serine >20% powder 50 mg
Vitamin E 10 mg
(83% VNR*)
*NRV: Nutrient Reference Values

How to use
Take one capsule daily with a glass of water.

Warnings
- Do not exceed the recommended daily dose.
- Keep out of reach of children under 3 years.
- Food supplements should not be considered a substitute for a varied, healthy, balanced diet and a healthy lifestyle.
- Do not take in case of suspected or confirmed hypersensitivity to one or more ingredients present in the product.
- Best before the date indicated, in intact packaging and stored correctly.
- Due to the origin of some ingredients, there may be variations in color from batch to batch which do not affect their validity.
- For use of the product by pregnant and breastfeeding women, seek medical advice.
- Contains naturally occurring sugars.

Conservation
Store the product in a cool, dry place away from heat, light and humidity.

Format
30 capsules of 535 mg.
Net weight: 16.05 g.

843P

REVISION 30 CAPSULES

REVISION 30 CAPSULES

MINSAN code: 985823071
Previous price: €22,43
Regular price €22,43
Regular price €23,00 Sale price €22,43
-2% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.